CN104829738A - Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes - Google Patents
Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes Download PDFInfo
- Publication number
- CN104829738A CN104829738A CN201510237905.5A CN201510237905A CN104829738A CN 104829738 A CN104829738 A CN 104829738A CN 201510237905 A CN201510237905 A CN 201510237905A CN 104829738 A CN104829738 A CN 104829738A
- Authority
- CN
- China
- Prior art keywords
- grass
- blade
- sargassan
- extract
- sargassun
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 126
- 230000000968 intestinal effect Effects 0.000 title claims abstract description 18
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 14
- 230000006872 improvement Effects 0.000 title claims abstract description 5
- 150000004676 glycans Chemical class 0.000 title abstract description 77
- 239000005017 polysaccharide Substances 0.000 title abstract description 77
- 229920001282 polysaccharide Polymers 0.000 title abstract description 77
- 241000195474 Sargassum Species 0.000 title abstract description 14
- 230000002265 prevention Effects 0.000 title abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 100
- 239000000843 powder Substances 0.000 claims abstract description 66
- 238000001035 drying Methods 0.000 claims abstract description 48
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 35
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000000605 extraction Methods 0.000 claims abstract description 16
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 11
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 238000010992 reflux Methods 0.000 claims abstract description 9
- 239000002904 solvent Substances 0.000 claims abstract description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 4
- 244000025254 Cannabis sativa Species 0.000 claims description 179
- 239000007788 liquid Substances 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 21
- 244000005709 gut microbiome Species 0.000 claims description 19
- -1 polyoxyethylene Polymers 0.000 claims description 17
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 238000000746 purification Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 208000008589 Obesity Diseases 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 6
- 235000020824 obesity Nutrition 0.000 claims description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 5
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 5
- 230000001965 increasing effect Effects 0.000 claims description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- 150000002334 glycols Chemical class 0.000 claims description 4
- 230000003053 immunization Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- 241000186000 Bifidobacterium Species 0.000 claims description 3
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 abstract description 11
- 208000030159 metabolic disease Diseases 0.000 abstract description 7
- 238000002474 experimental method Methods 0.000 abstract description 5
- 230000004071 biological effect Effects 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 241001465754 Metazoa Species 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract 1
- 239000012043 crude product Substances 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 238000005259 measurement Methods 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 8
- 238000007710 freezing Methods 0.000 description 7
- 229920000159 gelatin Polymers 0.000 description 7
- 239000008273 gelatin Substances 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000037396 body weight Effects 0.000 description 6
- 230000008030 elimination Effects 0.000 description 6
- 238000003379 elimination reaction Methods 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 208000016097 disease of metabolism Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 3
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 3
- 229910052939 potassium sulfate Inorganic materials 0.000 description 3
- 235000011151 potassium sulphates Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 206010042566 Superinfection Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 2
- 229940045511 barium chloride Drugs 0.000 description 2
- 229910001626 barium chloride Inorganic materials 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000212297 Pelvetia Species 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- 241000195475 Sargassaceae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 208000017580 chronic wasting disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000000874 microwave-assisted extraction Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000955 splenic vein Anatomy 0.000 description 1
- 238000012916 structural analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to an application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes. Concretely, the invention provides a sargassum graminifolium polysaccharide extract. A preparation method of the sargassum graminifolium polysaccharide extract comprises the following steps: drying, and crushing, so that sargassum graminifolium dry powder is obtained; carrying out ethanol reflux extraction, so that dry and defatted sargassum graminifolium powder is obtained; extracting the dry and defatted sargassum graminifolium powder by utilizing microwave and taking water as a solvent; separating and purifying extracting solution with a polyethyleneglycol/inorganic salt or ethanol/inorganic salt aqueous two-phase system; and collecting in inorganic salt bottom phase, filtering and concentrating by adopting an ultrafiltration membrane, and drying, so that the sargassum graminifolium polysaccharide extract is obtained. The sargassum graminifolium polysaccharide extract has high purity and good biological activity, and animal experiments verify that the intestinal flora can be obviously improved, and immunity of mouse can be obviously improved, so that the sargassum graminifolium polysaccharide extract can be used for preparing a medicine, health product or food which can be used for improving the intestinal flora and preventing and treating metabolic diseases such as diabetes.
Description
Technical field
The present invention relates to sargassan extract, specifically, relate to a kind of new blade of grass sargassan extract, and prevent and treat application in the metabolic diseases such as diabetes improving intestinal microflora.
Background technology
Sargassun (Sargassum) is phaeophyta siliquosa Pelvetia order Sargassaceae plant.Blade of grass sargassun (Sargassum.graminifolium.turn) belongs to the one of Sargassum, be grown on the cay of low tide band and subtidal zone, frond green or brown, height about 50 centimetres, be distributed in Zhoushan Of Zhejiang Province, Xiangshan, Fujian, Guangdong and Macao in China coastal, resource is very abundant.
Sargassun is the same also containing various bioactivators such as abundant polysaccharide, brown algae polyphenols, gamma-linolenic acid, amino acid and trace elements with the marine alga of other classes; Wherein, sargassan is that the one extracted from sargassun is soluble in water, the more much higher saccharide complex of viscosity, receives much concern especially because of its higher pharmaceutical use.Sargassum polysaccharides is a class polysaccharide specific to marine alga, has biological activity widely, comprises anti-freezing, anti-oxidant, antiviral, antitumor and immunoregulatory activity.But the domestic and international research majority to sargassan concentrates on extraction and isolation, structural analysis and antitumor, antianaphylaxis and prevents and treats urinary stone disease aspect at present.
In recent years, increasing focus of attention is to the importance of intestinal microflora to human health.The mankind and microorganism common evolutionary millions of year, human intestinal forms a large amount of normal microflora in the process, these floras form the interactional physiological entity with host by specific mode in enteron aisle, play a series of physiological actions such as nutrition, immunity, metabolism.Some disease of the mankind causes because microorganism is unbalance, instead of due to the existence of certain pathogenic microorganism, developing of the diseases such as such as anaphylactic disease, obesity, inflammatory bowel.Flora imbalance can cause superinfection or superinfection.Being more common in of flora imbalance uses microbiotic and chronic wasting disease etc.
Present stage, the relative disease Prevention and Curation such as the obesity cause high fat height sugar and diabetes there is no very good method, and diabetes prevalence remains high, and have become the Social Events threatening health of people.In recent years large quantity research shows, the quantity of the Bacterial community in diabetic subject's enteron aisle, flora ratio and flora all has different with normal people, intestinal microflora imbalance may cause intracellular toxin to enter blood, bring out chronic inflammatory diseases, thus destroy insulin receptor, injured blood vessel, interference lipid metabolism process, finally to cause fat, the metabolic disease such as diabetes.Be that target spot research metabolic disease has become the important research field of prevention and treatment of chronic diseases with intestinal microflora, but have at present the medicine of precise effects and natural product actually rare.
At present about the adjustable intestinal microflora of sargassan, the purposes of preventing and treating metabolic disease (as diabetes, obesity etc.) aspect further have not been reported.
Summary of the invention
The object of the invention is for deficiency of the prior art, a kind of blade of grass sargassan extract is provided and is improving the application in intestinal microflora control metabolic disease.
The invention provides a kind of blade of grass sargassan extract, it prepares by the following method:
A (), by raw material blade of grass sargassun crushed after being dried, is crossed 10-40 mesh sieve and is obtained blade of grass sargassun dry powder;
B () adds refluxing extraction 2-4 hour after the ethanol of volume fraction 70%-90% in blade of grass sargassun dry powder, material liquid volume is than being 1:5-10, and backflow terminates rear removing ethanol, dries, obtains the blade of grass sargassun powder of drying defatted;
C () selects power to be that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 500-1000 watt, material liquid volume is than being 1:10-30, and each microwave treatment time is 15-30 minute, altogether microwave treatment 1-4 time;
D () merges all extracting solutions, filter, filtrate utilizes polyoxyethylene glycol/inorganic salt or ethanol/inorganic salt aqueous two-phase system separation and purification, is placed in constant temperature oscillator and vibrates at 40-50 DEG C 25-35 minute, leaves standstill; Described polyoxyethylene glycol or the mass concentration of ethanol are 10%-40%, and described inorganic salt are selected from ammonium sulfate, sodium sulfate, dipotassium hydrogen phosphate or sodium-chlor, and mass concentration is 10%-25%;
Phase under (e) collection inorganic salt, employing ultrafiltration membrance filter concentrates, described ultra-filtration membrane operating pressure is 0.1-0.6MPa, the molecular weight cut-off of ultra-filtration membrane is 3000-20000Da, ultrafiltration time 20-40min, ultrafiltrate temperature 30-40 DEG C, the trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains described blade of grass sargassan extract.
Preferably, the aqueous two-phase system described in step (d) is polyoxyethylene glycol/inorganic salt, and described inorganic salt are ammonium sulfate.
More preferably, described molecular weight polyethylene glycol is 6000, and mass concentration is 10%-20%; Described Inorganic salt is 20%-25%.
Preferably, in step (d), temperature is 50 DEG C.
Preferably, in described blade of grass sargassan extract, sulfate radical content is 19.6%-25.6%.
Present invention also offers described blade of grass sargassan extract and prepare the application in medicine, healthcare products or the food improving intestinal microflora.
As a kind of concrete embodiment, described improvement intestinal microflora refers to be increased intestinal bifidobacteria and lactobacillus quantity and reduces enteron aisle intestinal bacteria and suis quantity.
Present invention also offers described blade of grass sargassan extract and prepare the application in medicine, healthcare products or the food preventing and treating diabetes or obesity.
Present invention also offers described blade of grass sargassan extract and prepare the application in medicine, healthcare products or the food improving immunizing power.
Blade of grass sargassan extract of the present invention can join in the food such as milk-product, bread, noodles such as tap water, functional beverage, drinks, all kinds of seasonings, Yoghourt, improves the sanatory effect of intestinal microflora to give full play to.
When blade of grass sargassan extract of the present invention is for the preparation of medicine, healthcare products or food, can be made into various forms of dosage form, comprise tablet, capsule, granule or oral liquid and can pre-conceivable nanometer formulation and targeting drug administration preparation etc.Described preparation is preferably that the blade of grass sargassan extract of 1%-99% and the pharmaceutical excipient of 99%-1% or additives form by weight percent.
The invention has the advantages that: the invention provides a kind of blade of grass sargassan extract, its purity is high, biological activity good, confirm that this blade of grass sargassan extract significantly can improve intestinal microflora through experimentation on animals, and significantly improve the immunizing power of mouse, therefore can be used for preparing the medicine, healthcare products or the food that improve intestinal microflora, for preventing and treating the metabolic disease such as diabetes, obesity.
Embodiment
Below embodiment provided by the invention is elaborated.
The preparation (one) of embodiment 1 blade of grass sargassan of the present invention extract
1, method steps
The preparation of 1.1 blade of grass sargassan extracts
(1) raw material blade of grass sargassun removed impurity and wash, clean blade of grass sargassun is put into drying baker, 30 DEG C of dryings 20 are little of constant weight, then dried blade of grass sargassun is obtained powder in crusher for crushing, cross 20 mesh sieves and obtain blade of grass sargassun dry powder, freezing is for subsequent use.
(2) in blade of grass sargassun dry powder, add refluxing extraction 3 hours after the ethanol of volume fraction 80%, solid-liquid ratio (blade of grass sargassun dry powder volume: ethanol contend) is 1:8.Backflow terminates rear elimination ethanol, is then positioned in stink cupboard by blade of grass sargassun powder and ethanol is volatilized completely, and finally that blade of grass sargassun powder is dry in drying baker, drying temperature is 30 DEG C, is dried to constant weight, for subsequent use.
(3) the blade of grass sargassun powder microwave radiation exaraction of drying defatted is got: selected frequency is 2450MHz, power is that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 800 watts, solid-liquid ratio (the blade of grass sargassun powder volume of drying defatted: volume of water) is 1:20, each microwave treatment time is 20 minutes, altogether microwave treatment 3 times.
(4) merge all extracting solutions, filter, filtrate utilizes polyoxyethylene glycol (PEG)/inorganic salt aqueous two-phase system separation and purification blade of grass sargassan, molecular weight polyethylene glycol 6000 in two phase aqueous extraction system, and mass concentration is 10%; Inorganic salt are ammonium sulfate, and mass concentration is 20%.Be placed in constant temperature oscillator to vibrate 30 minutes at 50 DEG C.Be divided into two-phase after leaving standstill, blade of grass sargassan enters phase under inorganic salt.
(5) phase under the inorganic salt obtained, adopt ultrafiltration membrance filter to concentrate, ultra-filtration membrane operating pressure is 0.15MPa, and the molecular weight cut-off of film is 10000Da, ultrafiltration time 30min, ultrafiltrate temperature 35 DEG C.Trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains blade of grass sargassan extract.The mensuration of polysaccharide content, polysaccharide extract rate in 1.2 Crude polysaccharides yield, crude product
(1) collect the microwave extraction liquid of above-mentioned steps (3), be condensed into medicinal extract, dry and obtain Crude polysaccharides.Crude polysaccharides yield %=(the total Crude polysaccharides quality/raw materials quality of gained) × 100%.
(2) phenol-sulfuric acid and colorimetric method is adopted to measure the content of polysaccharide in crude product.With glucose as a standard product, accurately take standard glucose 20mg in 500ml volumetric flask, add water to scale, draw 0 respectively, 0.2,0.4,0.6,0.8,1.0,1.2,1.4,1.6ml solution is in scale test tube, again each with distilled water mend to 2.0ml, then 6% phenol 1.0ml and vitriol oil 5.0ml is added, shake up cooling, room temperature is placed after 20 minutes and is measured absorbance in 490nm, X-coordinate is glucose concn μ g/ml, ordinate zou is absorbance, and drawing standard curve, obtains equation of linear regression.Crude polysaccharides 2mg is got under similarity condition, be settled in 50ml volumetric flask, draw in 1.0ml liquid to be measured to scale test tube and use distilled water polishing to 2.0ml, then add 6% phenol 1.0ml and vitriol oil 5.0ml, shake up cooling, room temperature is placed after 20 minutes and is measured absorbance in 490nm.The concentration C of liquid to be measured is calculated according to typical curve before.Polysaccharide content %=[Crude polysaccharides quality is got by (C × 1000 × 50)/institute] × 100% in crude product.
(3) polysaccharide extract rate %=polysaccharide quality/raw materials quality=(in crude product the total Crude polysaccharides quality of polysaccharide content % × gained)/raw materials quality.
The mensuration of 1.3 blade of grass sargassan purity
Purity=(polysaccharide content in blade of grass sargassan extract/blade of grass sargassan extract weight) × 100% of blade of grass sargassan.
The mensuration of sulfate radical content in 1.4 blade of grass sargassan extracts
Barium sulfate turbidimetry is adopted to measure sulfate content.
(1) experimental principle
Polysaccharide, by hydrochloric acid hydrolysis, discharges sulfate.Sulfate and bariumchloride generate barium sulfate.360nm place measure its absorbancy, sulfate content and its absorbancy linear.General potassium sulfate, as standard substance, calculates the content of sulfate.
(2) configuration of experiment reagent
1. the preparation of potassium sulfate standardized solution: accurately take the potassium sulfate 200mg being dried to constant weight through 105 DEG C, be settled to 200mL with the hydrochloric acid soln of lmoL/L, obtain sulfate standard reserving solution.
2. the configuration of 1moL/L HCl: 36%-38% concentrated hydrochloric acid 83.333mL is settled to 1L volumetric flask.
3. 0.5% gelatin: 1.25g gelatin is dissolved in 200mL water at 60-70 DEG C, is settled to 250mL volumetric flask after cooling.
4. l% bariumchloride-gelatin: 1g bariumchloride is dissolved in 100mL gelatin solution.
5. trichoroacetic acid(TCA): 3g trichoroacetic acid(TCA) is dissolved in 100mL distilled water.
(3) making of typical curve
Accurate absorption 0,0.04,0.08,0.12,0.16,0.2mL standard sulfate solution mends to 0.2mL in test tube with hydrochloric acid soln, using 0.2mL HCl solution as blank, add solution of trichloroacetic acid 3.8mL and bariumchloride-gelatin solution 1.0mL, shake up, room temperature leaves standstill 15min, survey optical density A1 in 360nm, separately replace bariumchloride-gelatin solution by same standardized solution series with gelatin test solution, obtain A2 using 0.2mL HCl solution as blank.With sulfate milligram number for X-coordinate, ordinate zou is that optical density (A1-A2) makes typical curve.
(4) process of blade of grass sargassan extract and mensuration
Precision took blade of grass sargassan extract 5mg and puts into the test tube filling 3mL 1mol/L HCl, sealing, in 100 DEG C of hydrolysis 6 hours.Get hydrolyzed solution 0.1mL and put into test tubes, add cumulative volume to 0.2mL with 1mol/L HCl solution, repeat operation during production standard curve, measure its light absorption value at 360nm place.In triplicate, its mean value is got.
2, result
Polysaccharide content, polysaccharide extract rate in 2.1 Crude polysaccharides yield, crude product
Polysaccharide content in Crude polysaccharides yield, crude product, polysaccharide extract rate measurement result be respectively 15.30%,
41.08%、6.285%。
2.2 blade of grass sargassan purity
The measurement result of blade of grass sargassan purity is 91.53%.
Sulfate radical content in 2.3 blade of grass sargassan extracts
In blade of grass sargassan extract, sulfate radical content is 25.6%.
The preparation (two) of embodiment 2 blade of grass sargassan of the present invention extract
1, method steps
(1) raw material blade of grass sargassun removed impurity and wash, clean blade of grass sargassun is put into drying baker, 20 DEG C of dryings 24 are little of constant weight, then dried blade of grass sargassun is obtained powder in crusher for crushing, cross 40 mesh sieves and obtain blade of grass sargassun dry powder, freezing is for subsequent use.
(2) in blade of grass sargassun dry powder, add refluxing extraction 2 hours after the ethanol of volume fraction 90%, solid-liquid ratio (blade of grass sargassun dry powder volume: ethanol contend) is 1:10.Backflow terminates rear elimination ethanol, is then positioned in stink cupboard by blade of grass sargassun powder and ethanol is volatilized completely, and finally that blade of grass sargassun powder is dry in drying baker, drying temperature is 20 DEG C, is dried to constant weight, for subsequent use.
(3) the blade of grass sargassun powder microwave radiation exaraction of drying defatted is got: selected frequency is 2450MHz, power is that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 500 watts, solid-liquid ratio (the blade of grass sargassun powder volume of drying defatted: volume of water) is 1:10, each microwave treatment time is 30 minutes, altogether microwave treatment 1 time.
(4) merge all extracting solutions, filter, filtrate utilizes polyoxyethylene glycol (PEG)/inorganic salt aqueous two-phase system separation and purification blade of grass sargassan, molecular weight polyethylene glycol 6000 in two phase aqueous extraction system, and mass concentration is 20%; Inorganic salt are sodium sulfate, and mass concentration is 25%.Be placed in constant temperature oscillator to vibrate 35 minutes at 40 DEG C.Be divided into two-phase after leaving standstill, blade of grass sargassan enters phase under inorganic salt.
(5) phase under the inorganic salt obtained, adopt ultrafiltration membrance filter to concentrate, ultra-filtration membrane operating pressure is 0.6MPa, and the molecular weight cut-off of film is 20000Da, ultrafiltration time 20min, ultrafiltrate temperature 40 DEG C.Trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains blade of grass sargassan extract.
Polysaccharide content, polysaccharide extract rate, blade of grass sargassan purity in Crude polysaccharides yield, crude product is measured according to the method for embodiment 1, and sulfate radical content in blade of grass sargassan extract.
2, result
Polysaccharide content, polysaccharide extract rate in 2.1 Crude polysaccharides yield, crude product
Polysaccharide content in Crude polysaccharides yield, crude product, polysaccharide extract rate measurement result be respectively 13.36%,
38.24%、5.109%。
2.2 blade of grass sargassan purity
The measurement result of blade of grass sargassan purity is 89.63%.
Sulfate radical content in 2.3 blade of grass sargassan extracts
In blade of grass sargassan extract, sulfate radical content is 24.8%.
The preparation (three) of embodiment 3 blade of grass sargassan of the present invention extract
1, method steps
(1) raw material blade of grass sargassun removed impurity and wash, clean blade of grass sargassun is put into drying baker, 40 DEG C of dryings 12 are little of constant weight, then dried blade of grass sargassun is obtained powder in crusher for crushing, cross 10 mesh sieves and obtain blade of grass sargassun dry powder, freezing is for subsequent use.
(2) in blade of grass sargassun dry powder, add refluxing extraction 4 hours after the ethanol of volume fraction 70%, solid-liquid ratio (blade of grass sargassun dry powder volume: ethanol contend) is 1:5.Backflow terminates rear elimination ethanol, is then positioned in stink cupboard by blade of grass sargassun powder and ethanol is volatilized completely, and finally that blade of grass sargassun powder is dry in drying baker, drying temperature is 40 DEG C, is dried to constant weight, for subsequent use.
(3) the blade of grass sargassun powder microwave radiation exaraction of drying defatted is got: selected frequency is 2450MHz, power is that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 1000 watts, solid-liquid ratio (the blade of grass sargassun powder volume of drying defatted: volume of water) is 1:30, each microwave treatment time is 15 minutes, altogether microwave treatment 4 times.
(4) merge all extracting solutions, filter, filtrate utilizes ethanol/inorganic salt aqueous two-phase system separation and purification blade of grass sargassan, and in two phase aqueous extraction system, ethanol mass concentration is 20%; Inorganic salt are dipotassium hydrogen phosphate, and mass concentration is 10%.Be placed in constant temperature oscillator to vibrate 25 minutes at 45 DEG C.Be divided into two-phase after leaving standstill, blade of grass sargassan enters phase under inorganic salt.
(5) phase under the inorganic salt obtained, adopt ultrafiltration membrance filter to concentrate, ultra-filtration membrane operating pressure is 0.1MPa, and the molecular weight cut-off of film is 3000Da, ultrafiltration time 40min, ultrafiltrate temperature 20 DEG C.Trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains blade of grass sargassan extract.
Polysaccharide content, polysaccharide extract rate, blade of grass sargassan purity in Crude polysaccharides yield, crude product is measured according to the method for embodiment 1, and sulfate radical content in blade of grass sargassan extract.
2, result
Polysaccharide content, polysaccharide extract rate in 2.1 Crude polysaccharides yield, crude product
Polysaccharide content in Crude polysaccharides yield, crude product, polysaccharide extract rate measurement result be respectively 12.42%,
35.07%、4.356%。
2.2 blade of grass sargassan purity
The measurement result of blade of grass sargassan purity is 79.65%.
Sulfate radical content in 2.3 blade of grass sargassan extracts
In blade of grass sargassan extract, sulfate radical content is 20.3%.
The preparation (four) of embodiment 4 blade of grass sargassan of the present invention extract
1, method steps
(1) raw material blade of grass sargassun removed impurity and wash, clean blade of grass sargassun is put into drying baker, 30 DEG C of dryings 12 are little of constant weight, then dried blade of grass sargassun is obtained powder in crusher for crushing, cross 20 mesh sieves and obtain blade of grass sargassun dry powder, freezing is for subsequent use.
(2) in blade of grass sargassun dry powder, add refluxing extraction 3 hours after the ethanol of volume fraction 80%, solid-liquid ratio (blade of grass sargassun dry powder volume: ethanol contend) is 1:8.Backflow terminates rear elimination ethanol, is then positioned in stink cupboard by blade of grass sargassun powder and ethanol is volatilized completely, and finally that blade of grass sargassun powder is dry in drying baker, drying temperature is 30 DEG C, is dried to constant weight, for subsequent use.
(3) the blade of grass sargassun powder microwave radiation exaraction of drying defatted is got: selected frequency is 2450MHz, power is that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 800 watts, solid-liquid ratio (the blade of grass sargassun powder volume of drying defatted: volume of water) is 1:20, each microwave treatment time is 15 minutes, altogether microwave treatment 4 times.
(4) merge all extracting solutions, filter, filtrate utilizes polyoxyethylene glycol (PEG)/inorganic salt aqueous two-phase system separation and purification blade of grass sargassan, and in two phase aqueous extraction system, molecular weight polyethylene glycol is 6000, and mass concentration is 10%; Inorganic salt are sodium-chlor, and mass concentration is 20%.Be placed in constant temperature oscillator to vibrate 30 minutes at 40 DEG C.Be divided into two-phase after leaving standstill, blade of grass sargassan enters phase under inorganic salt.
(5) phase under the inorganic salt obtained, adopt ultrafiltration membrance filter to concentrate, ultra-filtration membrane operating pressure is 0.15MPa, and the molecular weight cut-off of film is 10000Da, ultrafiltration time 20min, ultrafiltrate temperature 30 DEG C.Trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains blade of grass sargassan extract.
Polysaccharide content, polysaccharide extract rate, blade of grass sargassan purity in Crude polysaccharides yield, crude product is measured according to the method for embodiment 1, and sulfate radical content in blade of grass sargassan extract.
2, result
Polysaccharide content, polysaccharide extract rate in 2.1 Crude polysaccharides yield, crude product
Polysaccharide content in Crude polysaccharides yield, crude product, polysaccharide extract rate measurement result be respectively 12.28%,
35.14%、4.315%。
2.2 blade of grass sargassan purity
The measurement result of blade of grass sargassan purity is 75.85%.
Sulfate radical content in 2.3 blade of grass sargassan extracts
In blade of grass sargassan extract, sulfate radical content is 19.6%.
The preparation (five) of embodiment 5 blade of grass sargassan of the present invention extract
1, method steps
(1) raw material blade of grass sargassun removed impurity and wash, clean blade of grass sargassun is put into drying baker, 40 DEG C of dryings 20 are little of constant weight, then dried blade of grass sargassun is obtained powder in crusher for crushing, cross 40 mesh sieves and obtain blade of grass sargassun dry powder, freezing is for subsequent use.
(2) in blade of grass sargassun dry powder, add refluxing extraction 2 hours after the ethanol of volume fraction 80%, solid-liquid ratio (blade of grass sargassun dry powder volume: ethanol contend) is 1:10.Backflow terminates rear elimination ethanol, is then positioned in stink cupboard by blade of grass sargassun powder and ethanol is volatilized completely, and finally that blade of grass sargassun powder is dry in drying baker, drying temperature is 40 DEG C, is dried to constant weight, for subsequent use.
(3) the blade of grass sargassun powder microwave radiation exaraction of drying defatted is got: selected frequency is 2450MHz, power is that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 500 watts, solid-liquid ratio (the blade of grass sargassun powder volume of drying defatted: volume of water) is 1:20, each microwave treatment time is 30 minutes, altogether microwave treatment 2 times.
(4) merge all extracting solutions, filter, filtrate utilizes ethanol/inorganic salt aqueous two-phase system separation and purification blade of grass sargassan, and in two phase aqueous extraction system, ethanol mass concentration is 40%; Inorganic salt are sodium sulfate, and mass concentration is 20%.Be placed in constant temperature oscillator to vibrate 30 minutes at 40 DEG C.Be divided into two-phase after leaving standstill, blade of grass sargassan enters phase under inorganic salt.
(5) phase under the inorganic salt obtained, adopt ultrafiltration membrance filter to concentrate, ultra-filtration membrane operating pressure is 0.15MPa, and the molecular weight cut-off of film is 10000Da, ultrafiltration time 20min, ultrafiltrate temperature 30 DEG C.Trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains blade of grass sargassan extract.
Polysaccharide content, polysaccharide extract rate, blade of grass sargassan purity in Crude polysaccharides yield, crude product is measured according to the method for embodiment 1, and sulfate radical content in blade of grass sargassan extract.
2, result
Polysaccharide content, polysaccharide extract rate in 2.1 Crude polysaccharides yield, crude product
Polysaccharide content in Crude polysaccharides yield, crude product, polysaccharide extract rate measurement result be respectively 13.59%,
38.83%、5.277%。
2.2 blade of grass sargassan purity
The measurement result of blade of grass sargassan purity is 75.19%.
Sulfate radical content in 2.3 blade of grass sargassan extracts
In blade of grass sargassan extract, sulfate radical content is 20.7%.
Comparative example 1
(1) raw material blade of grass sargassun removed impurity and wash, clean blade of grass sargassun is put into drying baker, 30 DEG C of dryings 20 are little of constant weight, then dried blade of grass sargassun is obtained powder in crusher for crushing, cross 20 mesh sieves and obtain blade of grass sargassun dry powder, freezing is for subsequent use.
(2) in blade of grass sargassun dry powder, add refluxing extraction 3 hours after the ethanol of volume fraction 80%, solid-liquid ratio (blade of grass sargassun dry powder volume: ethanol contend) is 1:8.Backflow terminates rear elimination ethanol, is then positioned in stink cupboard by blade of grass sargassun powder and ethanol is volatilized completely, and finally that blade of grass sargassun powder is dry in drying baker, drying temperature is 30 DEG C, is dried to constant weight, for subsequent use.
(3) the blade of grass sargassun powder microwave radiation exaraction of drying defatted is got: selected frequency is 2450MHz, power is that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 800 watts, solid-liquid ratio (the blade of grass sargassun powder volume of drying defatted: volume of water) is 1:15, each microwave treatment time is 15 minutes, altogether microwave treatment 4 times.
(4) merge all extracting solutions, filter, filtrate utilizes polyoxyethylene glycol (PEG)/inorganic salt aqueous two-phase system separation and purification blade of grass sargassan, molecular weight polyethylene glycol 6000 in two phase aqueous extraction system, and mass concentration is 10%; Inorganic salt are zinc sulfate, and mass concentration is 25%.Be placed in constant temperature oscillator to vibrate 30 minutes at 50 DEG C.Be divided into two-phase after leaving standstill, blade of grass sargassan enters phase under inorganic salt.
(5) phase under the inorganic salt obtained, adopt ultrafiltration membrance filter to concentrate, ultra-filtration membrane operating pressure is 0.15MPa, and the molecular weight cut-off of film is 10000Da, ultrafiltration time 30min, ultrafiltrate temperature 35 DEG C.Trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains blade of grass sargassan extract.
Polysaccharide content, polysaccharide extract rate, blade of grass sargassan purity in Crude polysaccharides yield, crude product is measured according to the method for embodiment 1, and sulfate radical content in blade of grass sargassan extract.
2, result
Polysaccharide content, polysaccharide extract rate in 2.1 Crude polysaccharides yield, crude product
Polysaccharide content in Crude polysaccharides yield, crude product, polysaccharide extract rate measurement result be respectively 14.04%,
39.16%、5.498%。
2.2 blade of grass sargassan purity
The measurement result of blade of grass sargassan purity is 72.50%.
Sulfate radical content in 2.3 blade of grass sargassan extracts
In blade of grass sargassan extract, sulfate radical content is 12.8%.
Embodiment 6 blade of grass sargassan of the present invention extract improves intestinal microflora experiment
1, method
The foundation of 1.1 mouse intestinal flora imbalance models and administration
The male c57BL/6J mouse of cleaning grade, 8 weeks ages of mouse, body weight 18-20g.
Modeling method: after mouse adaptability raises one week, feeding high lipid food.The formula of high lipid food reference literature report: normal diet 60%, lard 12%, sucrose 5%, milk powder 5%, peanut 5%, egg 10%, sesame oil 2%, salt 1%.During modeling, all mouse all freely ingest, drink water, and feed and water change 1 time every day, weigh Mouse Weight 1 time weekly.All mouse continue nursing 8 weeks.Rejecting body weight is the animal more than 10% lower than 30g and the gavage body weight range of decrease.
Successful for induction obese model mouse is divided into model control group and embodiment 1 extract high, medium and low dosed administration group and the high, medium and low dosed administration group of comparative example 1 extract at random by body weight and blood sugar.Then model control group mouse gives oral distilled water, other groups give corresponding blade of grass sargassan extract, once a day, each according to table 1 administration, continuous 90 days, wherein, for the embodiment 1 extract high, medium and low dosed administration group in table 1 and the high, medium and low dosed administration group of comparative example 1 extract, described dosage refers to blade of grass sargassan dosage pure in extract.After last administration, put to death mouse, get its rectum section content and carry out microbial culture.
Table 1 dosage and time
1.2 intestinal microfloras detect
Every cage gets about 0.2g mouse fresh excreta with aseptic procedure, is placed in sterile centrifugation tube, adds appropriate physiological saline by 1:10, vortex 15min, make it homogenize, and then carries out 10 times of serial dilutions to 10
-1-10
-7.Adopt suitable extent of dilution according to the substratum selected, drip kind with liquid getting device, carry out aerobic and Anaerobic culturel respectively.Intestinal bacteria: adopt coliform EMB substratum, 37 DEG C, the aerobic cultivation of 24h; Bifidus bacillus: adopt the Medium of Bifidobacterium BBL that Qingdao Hai Bo Bioisystech Co., Ltd provides, 37 DEG C, 72h Anaerobic culturel; Suis: adopt suis selective medium (TATAC), 37 DEG C, the aerobic or amphimicrobian of 24-72h is cultivated; Lactobacillus: adopt MRS substratum, 37 DEG C, 72h Anaerobic culturel.Finally count the colony number of each ware.
Bacterial count (CFU/g)=colony number × extension rate (10 of every gram of ight soil
nheavy (the g) × saline volume (ml) of) × 20+ sample.Result represents with the logarithmic value log CFU/g of the bacteria colony count in every gram of ight soil.
In this experiment, within every two weeks, collect mouse fresh excreta, observe pharmacological agent to the impact of intestinal microflora.Lactobacillus and bifidus bacillus as the probiotic bacterium in mouse intestinal, by reducing gut pH or suppressing the field planting of harmful bacteria in enteron aisle and growth by the shielding Competition in space, nutrition.
2, result
The results are shown in Table 2.At experimental session, the intestinal bacteria quantity of each dosage group of blade of grass sargassan extract is lower than model control group, and bifidus bacillus and lactobacillus quantity are higher than model control group.And having dependency with dosage, dosage is higher, and the value changing intestinal microflora is more obvious.These results show, and blade of grass sargassan extract can promote the propagation of probiotics milk-acid bacteria, bifidus bacillus in enteron aisle, and can suppress or reduce the growth of pathogenic bacteria and intestinal bacteria etc., are conducive to the balance and the state of health that keep intestinal environment.From embodiment 1 and comparative example 1 corresponding dosage group comparative result, blade of grass sargassan extract of the present invention is all significantly better than blade of grass sargassan extract prepared by comparative example 1 to the increasing action of bifidus bacillus and lactobacillus quantity and to the reducing effect of intestinal bacteria and suis quantity, shows that its biological activity is better.
Table 2 blade of grass sargassan extract is on the impact of obese model mouse intestinal flora
Note: with model control group ratio, * P < 0.05; With comparative example 1 extract corresponding dosage group ratio, #P < 0.05.Embodiment 7 blade of grass sargassan of the present invention extract is on the impact of immunologic function
1, method
The detection of 1.1 immune organ quality, body weight
The mouse that embodiment 6 is respectively organized after 90 days at successive administration, after mouse claims quality, is put to death and dissects, take out spleen and thymus gland, claim quality after blotting bloodstain with filter paper.Measure the ratio of internal organs/weight.
1.2 lymphocyte transformation experiments
The mouse of each group of embodiment 6 at successive administration after 90 days, asepticly gets spleen, is placed in the little plate filling appropriate aseptic Hank's liquid, makes cell suspension, living cell counting number, be inoculated in 24 well culture plates with RPMI RPMI-1640 adjustment cell concn.Each sample establishes ConA liquid and control wells, puts 5% carbonic acid gas, cultivates 72h for 37 DEG C.Cultivation terminates front 4h, and every hole sucks supernatant liquor 0.7mL gently, adds not containing the former RPMI1640 nutrient solution of calf serum, adds MTT (5mg/mL) simultaneously and measures absorbance in 550nm wavelength.Lymphocytic multiplication capacity deducts with the absorbance adding ConA hole the absorbance not adding ConA hole and represents.
2, result
2.1 immune organ quality, body weight detected result
After medication, each group mouse immune organ weight compares in table 3.Result shows, and blade of grass sargassan extract has the effect increasing index and spleen index, and the effect of blade of grass sargassan extract of the present invention is more remarkable.
Table 3 respectively group mouse immune organ weight compares
Group | Dosage (mg/kg) | Index and spleen index | Thymus index |
Model control group | 0 | 3.065±0.052 | 3.215±0.067 |
Embodiment 1 extract low dose group | 50 | 3.518±0.031 | 3.626±0.303 |
Dosage group in embodiment 2 extract | 100 | 4.557±0.056* | 3.754±0.148 |
Embodiment 3 extract high dose group | 200 | 5.162±0.027**# | 3.952±0.072 |
Comparative example 1 extract low dose group | 50 | 3.319±0.032 | 3.521±0.105 |
Dosage group in comparative example 2 extract | 100 | 3.766±0.041 | 3.598±0.163 |
Comparative example 3 extract high dose group | 200 | 4.283±0.039* | 3.687±0.085 |
Note: with model control group ratio, * * P < 0.01, * P < 0.05; With comparative example 1 extract corresponding dosage group ratio, #P < 0.05.
2.2 lymphocyte transformation experimental results
Lymphocyte transformation experimental result is in table 4.
Table 4 lymphocyte transformation experimental result
Group | Dosage (mg/kg) | Splenic vein hemodynamics rate (%) |
Model control group | 0 | 36±2 |
Embodiment 1 extract low dose group | 50 | 39±3 |
Dosage group in embodiment 2 extract | 100 | 43±4* |
Embodiment 3 extract high dose group | 200 | 49±3**# |
Comparative example 1 extract low dose group | 50 | 38±2 |
Dosage group in comparative example 2 extract | 100 | 39±2 |
Comparative example 3 extract high dose group | 200 | 42±3* |
Note: with model control group ratio, * * P < 0.01, * P < 0.05, with comparative example 1 extract corresponding dosage group ratio, #P < 0.05.
In sum, blade of grass sargassan extract of the present invention can promote the propagation of lactobacillus, bifidus bacillus in diabetic mice enteron aisle, suppress intestinal bacteria and streptococcic growth simultaneously, recover the normal eubiosis of enteron aisle, and obviously can increase index and spleen index and increase cellular immune function.Above result shows, blade of grass sargassan extract tool of the present invention is significantly improved intestinal microflora and improves the effect of immunizing power.
The above is only the preferred embodiment of the present invention; it should be pointed out that for those skilled in the art, under the prerequisite not departing from the inventive method; can also make some improvement and supplement, these improve and supplement and also should be considered as protection scope of the present invention.
Claims (9)
1. a blade of grass sargassan extract, is characterized in that, it prepares by the following method:
A (), by raw material blade of grass sargassun crushed after being dried, is crossed 10-40 mesh sieve and is obtained blade of grass sargassun dry powder;
B () adds refluxing extraction 2-4 hour after the ethanol of volume fraction 70%-90% in blade of grass sargassun dry powder, material liquid volume is than being 1:5-10, and backflow terminates rear removing ethanol, dries, obtains the blade of grass sargassun powder of drying defatted;
C () selects power to be that solvent extract to the blade of grass sargassun powder of drying defatted with water at the microwave of 500-1000 watt, material liquid volume is than being 1:10-30, and each microwave treatment time is 15-30 minute, altogether microwave treatment 1-4 time;
D () merges all extracting solutions, filter, filtrate utilizes polyoxyethylene glycol/inorganic salt or ethanol/inorganic salt aqueous two-phase system separation and purification, is placed in constant temperature oscillator and vibrates at 40-50 DEG C 25-35 minute, leaves standstill; Described polyoxyethylene glycol or the mass concentration of ethanol are 10%-40%, and described inorganic salt are selected from ammonium sulfate, sodium sulfate, dipotassium hydrogen phosphate or sodium-chlor, and mass concentration is 10%-25%;
Phase under (e) collection inorganic salt, employing ultrafiltration membrance filter concentrates, described ultra-filtration membrane operating pressure is 0.1-0.6MPa, the molecular weight cut-off of ultra-filtration membrane is 3000-20000Da, ultrafiltration time 20-40min, ultrafiltrate temperature 30-40 DEG C, the trapped fluid after concentrating ultrafiltration membrance filter carries out lyophilize, obtains described blade of grass sargassan extract.
2. blade of grass sargassan extract according to claim 1, is characterized in that, the aqueous two-phase system described in step (d) is polyoxyethylene glycol/inorganic salt, and described inorganic salt are ammonium sulfate.
3. blade of grass sargassan extract according to claim 2, is characterized in that, described molecular weight polyethylene glycol is 6000, and mass concentration is 10%-20%; Described Inorganic salt is 20%-25%.
4. blade of grass sargassan extract according to claim 1, is characterized in that, in step (d), temperature is 50 DEG C.
5. blade of grass sargassan extract according to claim 1, is characterized in that, in described blade of grass sargassan extract, sulfate radical content is 19.6%-25.6%.
6. the arbitrary described blade of grass sargassan extract of claim 1-5 is preparing the application in medicine, healthcare products or the food improving intestinal microflora.
7. application according to claim 6, is characterized in that, described improvement intestinal microflora refers to be increased intestinal bifidobacteria and lactobacillus quantity and reduce enteron aisle intestinal bacteria and suis quantity.
8. the arbitrary described blade of grass sargassan extract of claim 1-5 is preparing the application in medicine, healthcare products or the food preventing and treating diabetes or obesity.
9. the arbitrary described blade of grass sargassan extract of claim 1-5 is preparing the application in medicine, healthcare products or the food improving immunizing power.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510237905.5A CN104829738B (en) | 2015-05-12 | 2015-05-12 | Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510237905.5A CN104829738B (en) | 2015-05-12 | 2015-05-12 | Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104829738A true CN104829738A (en) | 2015-08-12 |
CN104829738B CN104829738B (en) | 2017-04-12 |
Family
ID=53807963
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510237905.5A Expired - Fee Related CN104829738B (en) | 2015-05-12 | 2015-05-12 | Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104829738B (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104829740A (en) * | 2015-05-12 | 2015-08-12 | 上海海洋大学 | Method for synchronously extracting sargassum graminifolium polysaccharide and sargassum graminifolium polyphenol from sargassum graminifolium |
CN105483183A (en) * | 2016-01-07 | 2016-04-13 | 福建农林大学 | Preparation method of sargassum oligosaccharide and application of sargassum oligosaccharide in hypoglycemic drugs |
CN106071985A (en) * | 2016-06-21 | 2016-11-09 | 锦州医科大学 | A kind of method improving pig flesh flavor and application |
CN106343076A (en) * | 2016-11-04 | 2017-01-25 | 广东海洋大学 | Processing method of sargassum polysaccharide tea bag |
CN106509895A (en) * | 2016-11-08 | 2017-03-22 | 全椒先奇医药科技有限公司 | Probiotic health-care product and preparation method thereof |
CN106892996A (en) * | 2017-04-01 | 2017-06-27 | 林婷 | One kind lifting immunity polysaccharide extract and its manufacture method |
CN109943893A (en) * | 2019-02-27 | 2019-06-28 | 唐卫兵 | A kind of preparation method of the warming natural nano bamboo fibre/cotton fiber composite material of long acting antibiotic |
KR20200046398A (en) * | 2018-10-24 | 2020-05-07 | 목포대학교산학협력단 | Composition for improving intestinal health containing extract of Sargassum thunbergii or Sargassum fusiforme |
CN112778435A (en) * | 2021-03-18 | 2021-05-11 | 广东工业大学 | Method for separating and purifying dendrobium officinale polysaccharide by aqueous two-phase extraction |
CN112920024A (en) * | 2021-01-30 | 2021-06-08 | 海南大学 | Sargassum stolonifera phenolic substance and extraction method and application thereof |
CN112961259A (en) * | 2021-03-16 | 2021-06-15 | 盐城工学院 | Preparation method of taurolimus polysaccharide and application of taurolimus polysaccharide in field of improving intestinal function |
CN114957500A (en) * | 2021-12-24 | 2022-08-30 | 济宁医学院 | Selenylation modification method for improving immunocompetence of Chinese yam polysaccharide and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102793715A (en) * | 2012-08-14 | 2012-11-28 | 华东理工大学 | Sargassum polysaccharide and application of Sargassum polysaccharide in medicine preparation used for treating kidney injury |
CN104829740A (en) * | 2015-05-12 | 2015-08-12 | 上海海洋大学 | Method for synchronously extracting sargassum graminifolium polysaccharide and sargassum graminifolium polyphenol from sargassum graminifolium |
-
2015
- 2015-05-12 CN CN201510237905.5A patent/CN104829738B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102793715A (en) * | 2012-08-14 | 2012-11-28 | 华东理工大学 | Sargassum polysaccharide and application of Sargassum polysaccharide in medicine preparation used for treating kidney injury |
CN104829740A (en) * | 2015-05-12 | 2015-08-12 | 上海海洋大学 | Method for synchronously extracting sargassum graminifolium polysaccharide and sargassum graminifolium polyphenol from sargassum graminifolium |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104829740A (en) * | 2015-05-12 | 2015-08-12 | 上海海洋大学 | Method for synchronously extracting sargassum graminifolium polysaccharide and sargassum graminifolium polyphenol from sargassum graminifolium |
CN105483183B (en) * | 2016-01-07 | 2019-05-10 | 福建农林大学 | A kind of preparation method of sargassum oligosaccharides and its application in hypoglycemic drug |
CN105483183A (en) * | 2016-01-07 | 2016-04-13 | 福建农林大学 | Preparation method of sargassum oligosaccharide and application of sargassum oligosaccharide in hypoglycemic drugs |
CN106071985A (en) * | 2016-06-21 | 2016-11-09 | 锦州医科大学 | A kind of method improving pig flesh flavor and application |
CN106343076A (en) * | 2016-11-04 | 2017-01-25 | 广东海洋大学 | Processing method of sargassum polysaccharide tea bag |
CN106509895A (en) * | 2016-11-08 | 2017-03-22 | 全椒先奇医药科技有限公司 | Probiotic health-care product and preparation method thereof |
CN106892996A (en) * | 2017-04-01 | 2017-06-27 | 林婷 | One kind lifting immunity polysaccharide extract and its manufacture method |
KR20200046398A (en) * | 2018-10-24 | 2020-05-07 | 목포대학교산학협력단 | Composition for improving intestinal health containing extract of Sargassum thunbergii or Sargassum fusiforme |
KR102225351B1 (en) | 2018-10-24 | 2021-03-09 | 목포대학교산학협력단 | Composition for improving intestinal health containing extract of Sargassum thunbergii |
CN109943893A (en) * | 2019-02-27 | 2019-06-28 | 唐卫兵 | A kind of preparation method of the warming natural nano bamboo fibre/cotton fiber composite material of long acting antibiotic |
CN112920024A (en) * | 2021-01-30 | 2021-06-08 | 海南大学 | Sargassum stolonifera phenolic substance and extraction method and application thereof |
CN112961259A (en) * | 2021-03-16 | 2021-06-15 | 盐城工学院 | Preparation method of taurolimus polysaccharide and application of taurolimus polysaccharide in field of improving intestinal function |
CN112778435A (en) * | 2021-03-18 | 2021-05-11 | 广东工业大学 | Method for separating and purifying dendrobium officinale polysaccharide by aqueous two-phase extraction |
CN114957500A (en) * | 2021-12-24 | 2022-08-30 | 济宁医学院 | Selenylation modification method for improving immunocompetence of Chinese yam polysaccharide and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN104829738B (en) | 2017-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104829738A (en) | Application of sargassum graminifolium polysaccharide extract in improvement of intestinal flora and prevention and treatment of diabetes | |
CN101474375B (en) | Compound Cordyceps militaris L. Link preparation and production method and application | |
CN105535650A (en) | Probiotic composition with anti-tumor function as well as preparation method and application thereof | |
CN105017438B (en) | A kind of Radix et Rhizoma Gynurae divaricatae polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food | |
CN101919875A (en) | Enteromorpha mushroom polysaccharide compound, preparation method and application as health-care medicament thereof | |
CN101805763A (en) | Inonotus obliquus extracellular and intracellular mixing crude polysaccharide with function of strengthening immunity | |
CN104013636B (en) | Watt careless Pentacyclic triterpene saponins compounds anti-tumor drug purposes | |
CN103070333B (en) | Cordyceps militaries (active substance) polysaccharide extraction and capsule preparation method | |
CN106421208B (en) | Pharmaceutical composition with chemical liver injury resistance function and preparation method thereof | |
CN105796587B (en) | Caulis bambusae in taenian polysaccharide immunological regulation, it is antitumor in application | |
CN104277136A (en) | Yellow river beach date polysaccharides, and extraction and refining method and application thereof | |
CN103651847A (en) | Formula donkey milk powder with function of coordinating intestinal flora | |
CN105661491A (en) | Peach gum health product and preparation method and application thereof | |
CN104825783B (en) | Chinese medicine composition with antitumor activity and its preparation method and application | |
CN101357142B (en) | Use of Clostridium butyricum in preparing medicine composition for preventing and treating cerebrovascular disease | |
CN104491834B (en) | Anti-gastric cancer health product containing european bird cherry polysaccharide | |
CN100544736C (en) | A kind of pharmaceutical composition of enhancing immunity and preparation method | |
CN103238711A (en) | Food healthcare tea granules for promoting lead excreting | |
CN105902561A (en) | Application of Gracilariopsis lemaneiformis polysaccharide as antitumor chemotherapy drug synergist and antitumor drug | |
CN104840716B (en) | Traditional Chinese medicine compound composition with anti-breast cancer activity and its preparation method and application | |
CN105274175A (en) | Solid fermentation process and antitumor activity of Fomitopsis pinicola | |
CN104288214B (en) | A kind of hay-scented composition of medicine, preparation method and applications | |
CN105012366B (en) | A kind of bright moon grass polysaccharide and its application in preparing for immunological regulation and anti-tumor drug and functional food | |
CN103655605A (en) | Application of fructan extract in preparing medicines, foods or health products for improving intestinal flora | |
CN103610759A (en) | Mushroom and fructus forsythiae mixed fermentation product for preventing chicken coccocidiosis and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170412 |